Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:31 pm Purchase |
2025-02-07 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 4,125,000 5.440% |
1,125,000 (+37.50%) |
Filing History |
| 2025-02-14 08:48 am Sale |
2024-12-31 | 13G | OnKure Therapeutics, Inc. OKUR |
Deep Track Capital, LP | 523,989 4.140% |
-136,147 (-20.62%) |
Filing History |
| 2025-02-14 08:48 am Sale |
2024-12-31 | 13G | Pyxis Oncology, Inc. PYXS |
Deep Track Capital, LP | 0 0.000% |
-4,184,100 (Position Closed) |
Filing History |
| 2025-02-14 08:46 am Purchase |
2024-12-31 | 13G | enGene Holdings Inc. Common Stock ENGN |
Deep Track Capital, LP | 4,557,575 8.940% |
2,307,575 (+102.56%) |
Filing History |
| 2025-02-14 08:45 am Sale |
2024-12-31 | 13G | Editas Medicine, Inc. EDIT |
Deep Track Capital, LP | 0 0.000% |
-5,473,086 (Position Closed) |
Filing History |
| 2025-02-14 08:44 am Sale |
2024-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
Deep Track Capital, LP | 3,460,756 4.650% |
-602,920 (-14.84%) |
Filing History |
| 2025-02-14 08:43 am Sale |
2024-12-31 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 1,975,998 1.070% |
-13,946,657 (-87.59%) |
Filing History |
| 2025-02-14 08:42 am Purchase |
2024-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 3,000,000 4.240% |
2,170 (+0.07%) |
Filing History |
| 2025-02-14 08:41 am Sale |
2024-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Deep Track Capital, LP | 0 0.000% |
-699,281 (Position Closed) |
Filing History |
| 2025-02-14 08:41 am Sale |
2024-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Deep Track Capital, LP | 3,330,236 6.710% |
-160,270 (-4.59%) |
Filing History |
| 2025-02-14 08:40 am Sale |
2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 609,900 1.320% |
-3,486,552 (-85.11%) |
Filing History |
| 2025-02-10 4:04 pm Purchase |
2025-02-03 | 13G | Tectonic Therapeutic, Inc. TECX |
Deep Track Capital, LP | 1,401,938 7.600% |
1,401,938 (New Position) |
Filing History |
| 2025-02-07 4:30 pm Purchase |
2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE |
Deep Track Capital, LP | 3,023,484 6.910% |
3,023,484 (New Position) |
Filing History |
| 2025-01-17 4:02 pm Purchase |
2025-01-10 | 13G | COMPASS Pathways plc CMPS |
Deep Track Capital, LP | 9,274,589 9.990% |
9,274,589 (New Position) |
Filing History |
| 2025-01-13 4:08 pm Purchase |
2025-01-06 | 13G | Structure Therapeutics Inc. GPCR |
Deep Track Capital, LP | 9,000,000 5.240% |
8,100,000 (+900.00%) |
Filing History |
| 2024-12-23 4:42 pm Purchase |
2024-12-23 | 13G | RAPT Therapeutics, Inc. RAPT |
Deep Track Capital, LP | 14,116,000 9.870% |
14,116,000 (New Position) |
Filing History |
| 2024-12-23 4:41 pm Purchase |
2024-12-19 | 13G | 89bio, Inc. ETNB |
Deep Track Capital, LP | 6,477,949 5.410% |
4,477,949 (+223.90%) |
Filing History |
| 2024-11-22 4:16 pm Sale |
2024-11-20 | 13G | Apellis Pharmaceuticals, Inc. APLS |
Deep Track Capital, LP | 6,000,000 4.820% |
-220,265 (-3.54%) |
Filing History |
| 2024-11-22 08:47 am Purchase |
2024-11-15 | 13G | Apellis Pharmaceuticals, Inc. APLS |
Deep Track Capital, LP | 6,220,265 5.000% |
6,220,265 (New Position) |
Filing History |
| 2024-11-14 10:19 am Sale |
2024-09-30 | 13G | Ambrx Biopharma Inc. AMAM |
Deep Track Capital, LP | 0 0.000% |
-3,710,412 (Position Closed) |
Filing History |